What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Antimicrobial agents and chemotherapy
American Society for Microbiology
MetadataShow full item record
Heyckendorf, J., Andres, S., Köser, C. U., Olaru, I. D., Schön, T., Sturegård, E., Beckert, P., et al. (2018). What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.. Antimicrobial agents and chemotherapy, 62 (2)https://doi.org/10.1128/aac.01550-17
Rapid and accurate drug-susceptibility testing (DST) is essential for the treatment of multi and extensively drug-resistant tuberculosis (M/XDR-TB). We compared the utility of genotypic DST assays with phenotypic DST (pDST) using BACTEC 960 MGIT or Löwenstein-Jensen to construct M/XDR-TB treatment regimens for a cohort of 25 consecutive M/XDR-TB patients and 15 possible anti-TB drugs. Genotypic DST results from Cepheid GeneXpert MTB/RIF (Xpert) and line probe assays (LPAs: Hain GenoType MTBDRplus 2.0 and MTBDRsl 2.0)] and whole genome sequencing (WGS) were translated into individual algorithm-derived treatment regimens for each patient. We further analysed if discrepancies between the various methods were due to flaws in the genotypic or phenotypic test using MIC results. Compared with pDST, the average agreement in the number of drugs prescribed in ‘genotypic’ regimens ranged from just 49% (95% CI 39-59%) for Xpert and 63% (95% CI 56-70%) for LPAs to 93% (95% CI 88-98%) for WGS. Only the WGS regimens did not comprise any drugs to which pDST showed resistance. Importantly, MIC testing revealed that pDST likely underestimated the true rate of resistance for key drugs (rifampicin, levofloxacin, moxifloxacin, and kanamycin) because critical concentrations (CCs) were too high. WGS can be used to rule-in resistance even in M/XDR strains with complex resistance patterns, but pDST for some drugs is still needed to confirm susceptibility and construct the final regimens. Some CCs for pDST need to be re-examined to avoid systematic false susceptible results in low-level resistant isolates.
Humans, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Rifampin, Antitubercular Agents, Bacterial Typing Techniques, Microbial Sensitivity Tests, Cohort Studies, Drug Resistance, Multiple, Bacterial, Genotype, Phenotype, Genome, Bacterial, Extensively Drug-Resistant Tuberculosis, Whole Genome Sequencing, Moxifloxacin, Kanamycin, Levofloxacin
Wellcome Trust (098600/Z/12/Z)
External DOI: https://doi.org/10.1128/aac.01550-17
This record's URL: https://www.repository.cam.ac.uk/handle/1810/271619
Attribution 4.0 International
Licence URL: http://creativecommons.org/licenses/by/4.0/
Recommended or similar items
The following licence files are associated with this item: